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CV Imaging: What Was New in 2012?Stephan Achenbach, MD,* Matthias G. Friedrich, MD,y Eike Nagel, MD,z
Christopher M. Kramer, MD,x Philip A. Kaufmann, MD,k Amir Farkhooy, MD,¶
Vasken Dilsizian, MD,# Frank A. Flachskampf, MD¶Erlangen, Germany; Montreal, Quebec, Canada; London, United Kingdom; Charlottesville, Virginia;
Zurich, Switzerland; Uppsala, Sweden; and Baltimore, MarylandEchocardiography, single-photon emission computed tomography (SPECT), positron emission
tomography (PET), cardiac magnetic resonance, and cardiac computed tomography can be used for
anatomic and functional imaging of the heart. All 4 methods are subject to continuous improvement.
Echocardiography beneﬁts from the more widespread availability of 3-dimensional imaging, strain and
strain rate analysis, and contrast applications. SPECT imaging continues to provide very valuable
prognostic data, and PET imaging, on the one hand, permits quantiﬁcation of coronary ﬂow reserve, a
strong prognostic predictor, and, on the other hand, can be used for molecular imaging, allowing the
analysis of extremely small-scale functional alterations in the heart. Magnetic resonance is gaining
increasing importance as a stress test, mainly through perfusion imaging, and continues to provide very
valuable prognostic information based on late gadolinium enhancement. Magnetic resonance coronary
angiography does not substantially contribute to clinical cardiology at this point in time. Computed
tomography imaging of the heart mainly concentrates on the imaging of coronary artery lumen and
plaque and has made substantial progress regarding outcome data. In this review, the current status of
the 5 imaging techniques is illustrated by reviewing pertinent publications of the year 2012. (J Am
Coll Cardiol Img 2013;6:714–34) ª 2013 by the American College of Cardiology FoundationEchocardiography
By far the most frequently applied modality of
cardiac imaging, echocardiography continues to
be indispensable for the practice of cardiology as
well as for cardiovascular research and, despite
going back 60 years since Inge Edler’s initial
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A B B R E V I A T I O N S
A N D A C R O N YM S
2D = 2-dimensional
3D = 3-dimensional
CI = conﬁdence interval
CT = computed tomography
CMR = cardiovascular magnetic
resonance
FFR = fractional ﬂow reserve
FFRCT = CT-derived fractional
ﬂow reserve
HFPEF = heart failure with
preserved ejection fraction
HR = hazard ratio
ICD = implantable cardioverter-
deﬁbrillator
LGE = late gadolinium
enhancement
OR = odds ratio
PET = positron emission
tomography
SPECT = single-photon emission
computed tomography
TEE = transesophageal
echocardiography
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715gradients, ﬂow volumes (by combining blood ﬂow
velocity with anatomic information), and valve oriﬁce
areas. Doppler imaging is not limited to blood ﬂow
but can also be used to analyze the motion of tissue,
which in turn permits applications such as imaging
of myocardial deformation (strain and strain rate).
Additional echocardiographic techniques include
3-dimensional echocardiography and contrast echo-
cardiographydall areas in which major progress
continues.
Morphology and function. Although echocardiog-
raphy has been available for decades, even the careful
analysis of cardiac morphology may produce new and
relevant information. For example, noncompaction
cardiomyopathy, although relatively newly recog-
nized as a disease entity, is often overdiagnosed; no
universally accepted standard of diagnosis exist.
Gebhard et al. (1) introduced a new criterion for the
diagnosis of this disease: the measurement of systolic
compacta thickness. They found that a systolic
thickness <8 mm of the compacted, outer layer of
myocardium in systole (the compacta), measured
in apical or mid-ventricular parasternal short-axis
views, successfully separated patients with cardio-
myopathy from patients with hypertrophy due to
aortic valve disease. It is generally recognized that
diagnosis of this disease is difﬁcult, and over-
diagnosis probably occurs frequently in individuals
with some degree of hypertrophy and prominent left
ventricular trabeculation.
Right ventricular assessment is more difﬁcult
than imaging of the left ventricle, given the irregular
shape of the right ventricle. This concerns both
morphology and function. In a study of the size of
the right ventricle in endurance athletes, 28% of
these individuals fulﬁlled the echocardiographic
criteria for arrhythmogenic right ventricular car-
diomyopathy (2). Hence, great caution should be
used when evaluating right heart dimensions in
endurance-trained persons. The authors also argued
that indexing for body surface area is suboptimal to
establish normal values because typically the rela-
tionship of cardiac dimensions to body surface area
is not linear.
Echocardiography is the standard tool to di-
agnose both systolic and diastolic dysfunction of the
left ventricle. For diagnosing diastolic dysfunction
in patients with heart failure and preserved ejection
fraction (HFPEF), the main parameters to consider
are left atrial volume, the ratio of peak transmitral
ﬂow velocity to peak early diastolic left ventricular
lengthening velocity (E/e0), and the transmitral
diastolic ﬂow proﬁle. Although ﬁlling pressures
cannot be measured directly by echocardiography, areasonably reliable diagnosis of elevated left ven-
tricular ﬁlling pressures can still be made in the
majority of patients. Increased left atrial volume is
already known as an essential cornerstone in the
diagnosis of HFPEF. New data from the I-PRE-
SERVE (Irbesartan in Heart Failure With Pre-
served Systolic Function) study in 745 patients
conﬁrm that HFPEF is associated with left ven-
tricular hypertrophy, increased left atrial size, and
other echocardiographic signs of diastolic dysfunc-
tion (3). Furthermore, these parameters signiﬁcantly
predict an adverse prognosis regarding mortality and
heart failure–related hospitalization.
Not only increased left atrial size, but alsodecreased left atrial function is relevant.
Russo et al. (4) showed in a community-
based study of 357 patients with predom-
inantly normal ejection fraction and in
sinus rhythm that minimum left atrial
volume (i.e., volume immediately after
mitral valve closure) correlated better with
the degree of diastolic dysfunction than
maximal (systolic) left atrial volume, which
is the standard measure. This might be
because minimum left atrial volume, in
contrast to maximum volume, contains
additional information on left atrial func-
tion, which may be affected earlier by dia-
stolic dysfunction than maximal left atrial
volume. These ﬁndings are conﬁrmed by
a study by Welles et al. (5) of 855 patients
with coronary artery disease and preserved
ejection fraction. Left atrial function was
measured by an echocardiographic index
and a strong linear relationship was seen
between a decrease in this index over time
and adverse cardiovascular outcomes.
Echocardiography permits quantiﬁca-
tion of left ventricular stroke volumes.
Analysis of stroke volume may provide
complementary information in one of the most
frequent disease entities studied by echocardiogra-
phy, aortic valve stenosis. Lancellotti et al. (6) fol-
lowed 150 asymptomatic patients with severe aortic
stenosis (oriﬁce area <1 cm2) and normal left ven-
tricular ejection fraction for >3 years (6). The pa-
tients were divided into 4 hemodynamically
different groups depending on left ventricular stroke
volume and mean pressure gradients. The study
showed that patients with low stroke volume/low
gradient aortic stenosis had markedly reduced car-
diac event-free survival (hazard ratio [HR]: 5.4)
compared with those with low stroke volume/high
gradient, suggesting that integrating stroke volume
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Figure 1. Adjusted Incidence of Cardiac Events According to
the Newly Proposed Classiﬁcation of Aortic Stenosis
HG ¼ high gradient; LF ¼ low ﬂow; LG ¼ low gradient; NF ¼
normal ﬂow. Reproduced, with permission, from Lancellotti
et al. (6).
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716data allows a better prediction of clinical outcomes
in patients with asymptomatic severe aortic stenosis
(Fig. 1).
New insights continue to be obtained even for the
assessment of cardiac morphology and function by
echocardiography. Larger-than-expected right heart
dimensions should be anticipated in endurance
athletes, and exercise function of the right ventricle
should be evaluated before concluding that a car-
diomyopathy is present. HFPEF is a topic of
increasing importance, and diastolic left ventricular
dysfunction, left atrial enlargement, and left atrial
dysfunction are closely linked.
3-dimensional echocardiography. Three-dimensional
(3D) echocardiography has a proven track record for
more accurate and reproducible assessment of left
ventricular volumes compared with 2-dimensional
(2D) imaging, even though some technical prob-
lems remain, and recalibration of “normal ranges”
may be necessary (7,8). The recognition of HFPEF
fraction as an important form of heart failure (see
previously) has renewed interest in left atrial volumes
because these are typically altered as a consequence
of diastolic left ventricular dysfunction, as already
discussed in the section on morphology and function.
A multicenter study comparing left atrial volume
calculation by transthoracic (biplane) 2D echocardi-
ography, transthoracic 3D echocardiography, and
magnetic resonance imaging as the gold standard
conﬁrmed higher accuracy and lower variability
for 3D echocardiography compared with 2D echo-
cardiography (9). This was true not only for maximal
but also for minimal left atrial volumes andcontributes to establishing 3D echocardiography as
the best echocardiographic method to measure atrial
dimensions. For the guidance of cardiac inter-
ventions, prominently mitral valve repair, 3D echo-
cardiography has become a cornerstone (10,11).
Strain and strain rate. Doppler echocardiography
can be used not only to measure blood ﬂow veloc-
ities, but also to measure tissue velocities, such as the
speed of motion of the left ventricular myocardium.
However, such velocity measurements would assess
the speed of motion relative to the transducer
and not the deformation (e.g., shortening) of the
myocardium independent from motion of the entire
heart and ventricular wall. Passive motion could
not be differentiated from active contraction.
This limitation is overcome by strain and strain
rate measurements. By comparing velocities of
small myocardial segments with relative to the
adjacent tissue, strain rate can be deriveddthe rate
of shortening speciﬁc to the respective piece of
myocardium, a measure of regional contractility.
Strain is the integral of strain rate; it determines the
overall amount of shortening in a given piece of
myocardium and is a measure of regional ejection
fraction (12). Strain and strain rate allow detailed
and quantitative analysis of left ventricular function
and can help differentiate speciﬁc disease entities.
For example, in patients with amyloidosis, Phelan
et al. (13) observed that apical segments seem to be
mostly “spared” from impairment of longitudinal
strain; this ﬁnding effectively distinguished patients
with cardiac amyloidosis from those with left ven-
tricular hypertrophy or hypertrophy due to aortic
stenosis.
The detailed and quantitative analysis of
myocardial contraction has been used to analyze
ischemic memory, a loosely deﬁned concept referring
to structural or functional changes in the myocar-
dium after a transient ischemic episode has resolved
(14). Different from infarction, no permanent
damage is caused by such a brief episode; however,
the structural or functional changes, although ulti-
mately reversible, last longer than impairment of
perfusion and therefore metaphorically have been
dubbed a memory. An example is the well-known
phenomenon of myocardial stunning. In a modi-
ﬁcation of previous work by Ishii et al. (15),
Asanuma et al. (16) demonstrated in an experi-
mental animal model that after a 2-min coronary
occlusion, post-systolic shortening (myocardial
shortening occurring after aortic valve closure) per-
sisted as long as 20 min after reperfusion. This could
be measured preferentially by speckle tracking–
based circumferential strain measurements (Fig. 2).
Figure 2. Strain and Strain Rate Proﬁles
(Top) End-systolic circumferential strain is color coded in the inner half of the myocardium. Orange color disappeared in the risk area (yellow
arrowheads) during coronary occlusion, indicating that end-systolic strain was near 0. (Middle) Circumferential strain proﬁles in the risk area
(orange line) and the normal area (blue line). Post-systolic shortening was demonstrated in the risk area during occlusion. Although systolic
strain recovered to the baseline level by 10 min after reperfusion, post-systolic shortening persisted until 30 min after reperfusion (red
arrows). (Bottom) Circumferential strain rate proﬁles in the risk area (orange line) and the normal area (blue line). Strain rate during early
diastole (pink arrows) decreased in the risk area during occlusion, but this decrease did not persist after reperfusion. End-systole is indicated
by the red dotted line. Reprinted, with permission, from Asanuma et al. (16).
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717Obviously, such observations, if reliably reproduc-
ible in a clinical context, might be very useful to
improve accuracy for ischemia detection at rest or
after a stress test.
Another example in which strain and strain rate
image may provide crucial information is the clinical
problem of low-ﬂow–low-gradient aortic valve ste-
nosis, a situation in which the assessment of the
degree of aortic valve stenosis may be very difﬁcult.
In a prospective cohort study of patients with aortic
stenosis by Herrmann et al. (17), the investigators
analyzed whether echocardiographic measurements
could detect myocardial ﬁbrosis, thus allowing the
differentiation between low-gradient, paradoxical
severe aortic stenosis with myocardial ﬁbrosis from
moderate aortic stenosis with similar gradients, but
without or with less ﬁbrosis. Myocardial ﬁbrosis was
quantiﬁed by contrast-enhanced magnetic reso-
nance imaging. On follow-up, patients with myo-
cardial ﬁbrosis had poorer outcomes than those with
little or no ﬁbrosis. Echocardiographic parameters
of longitudinal left ventricular function (mitral ringdisplacement or longitudinal strain rate) reliably
identiﬁed the functional consequences and thus the
presence of myocardial ﬁbrosis (Fig. 3).
Strain and strain rate imaging can also be applied
to the right ventricle. La Gerche et al. (18) analyzed
right ventricular function in endurance athletes with
right ventricular strain and strain rate measurements
and found lower than normal values at rest, with a
large increase with exercise.
Longitudinal left ventricular function may serve
as an indicator of early myocardial damage, even if
ejection fraction is preserved. This holds true for
ischemic damage as well as early cardiomyopathy,
ﬁbrotic myocardial remodeling in aortic stenosis,
and other conditions.
Contrast echocardiography. Contrast echocardiog-
raphy has been used, for example, for better quan-
tiﬁcation of left ventricular function and the analysis
of myocardial perfusion. As a reminder that fun-
damental technical improvements, although cur-
rently more sluggish than in CT or CMR, can also
be expected for echocardiography, a pre-clinical
Figure 3. Patient With a Typical Pattern of Low-Gradient Aortic Stenosis
(A) A 78-year-old woman with a septal and posterior wall of 13 mm, left ventricular end-
diastolic diameter of 40 mm, ejection fraction of 60%, aortic valve area of 0.9 cm2, and
mean gradient of 29 mm Hg. (B) Mitral ring displacement is 6 mm (normal value, <9 mm).
(C) Typical basal septal and lateral late enhancement (arrows) on cardiac magnetic reso-
nance imaging. (D) Marked myocardial ﬁbrosis on histology from intraoperative biopsy.
Reprinted, with permission, from Herrmann et al. (17).
Achenbach et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 6 , N O . 6 , 2 0 1 3
CV Imaging in 2012 J U N E 2 0 1 3 : 7 1 4 – 3 4
718report from Dave et al. (19) illustrates an ingenious
use of contrast echocardiography to determine the
absolute pressure level to which contrast agents are
exposed, harnessing an inverse relationship between
ambient pressure and reﬂectivity. More precisely,
the amplitude of reﬂection from a bubble at one
half of the insonation frequency is linearly and
inversely related to the pressure in the ﬂuid sur-
rounding the bubbles, a concept called “sub-
harmonic aided pressure estimation.” After proper
calibration, the researchers were able to track
remarkably well the left ventricular pressure curve
based on data extraction from (noninvasive) pulsed-
wave Doppler recordings of the left ventricle. If
robust enough, the applications of such a technique
would be legion.
Nuclear Cardiology (SPECT and PET)
SPECT and PET are the major techniques used in
nuclear cardiology, with SPECT being used in a
substantially larger portion of patients. Myocardial
perfusion imaging at rest and stress is the standard
approach to identify reversible defects of tracer
accumulation as a sign of exercise-induced hypo-
perfusion and/or ﬁxed defects at rest and stress
as a sign of myocardial scar. In addition to theirdiagnostic value, SPECT and PET imaging of
myocardial perfusion and viability have a strong
prognostic value. Patients with normal myocardial
perfusion at exercise have an excellent prognosis
regarding overall mortality and cardiovascular
events. In the presence of exercise-induced perfu-
sion defects, prognosis is impaired. Likely because
of its higher spatial resolution, PET provides a
better discrimination of low-risk from high-risk
disease than SPECT (20) (Fig. 4).
As opposed to SPECT, which provides only
qualitative evaluation of myocardial perfusion, PET
can be used for quantitative measurement of
myocardial blood ﬂow at rest and during stress
(measured in milliliter/gram/minute). The so-called
coronary ﬂow reserve can be obtained my dividing
myocardial blood ﬂow during stress by blood ﬂow at
rest and may be prognostically advantageous (21).
Especially in patients with diabetes, SPECT im-
aging may miss so-called balanced ischemia in the
presence of 3-vessel disease, and it is assumed that
the quantitative measurement of myocardial blood
ﬂow may have diagnostic advantages in this patient
group. In fact, Fiechter et al. (22) documented in 73
patients that the use of coronary ﬂow reserve
increased the sensitivity of perfusion PET from 79%
to 96%, with an unchanged speciﬁcity of 80%,
resulting in an improvement of the accuracy from
79% to 92%. Murthy et al. (23) performed a large
trial that included 1,172 patients with diabetes and
1,611 normoglycemic individuals to analyze the
prognostic value of coronary ﬂow reserve measured
by PET. After rest and dipyridamole imaging with
the perfusion-traced rubidium-82, patients were
followed for a median period of 1.4 years. The
annualized rate of cardiovascular death was 7.6% in
600 patients with diabetes and impaired ﬂow reserve
(here assumed as a value #1.6), but only 1.3% in
572 diabetic patients with normal ﬂow reserve
(>1.6). In 339 patients with diabetes but no pre-
existing coronary disease and a normal coronary
ﬂow reserve, the cardiac mortality rate was only
0.3%. This was not signiﬁcantly different from 759
individuals without diabetes and a normal coronary
ﬂow reserve (0.5%) (Fig. 5).
In a similar investigation, the same group of au-
thors analyzed the value of myocardial ﬂow reserve
in 866 patients with moderate to severe impairment
of renal function, which is known to be associated
with an increased risk of coronary events. Patients
were followed for a mean period of 1.28 years. After
adjustment for all risk factors, cardiac mortality was
more likely by a factor of 2.1 if ﬂow reserve
remained below the median (here: 1.5) (24).
Figure 4. Prognostic Value of SPECT and PET
Results of a meta-analysis demonstrate the prognostic implications
of a normal or slightly abnormal (low risk) versus moderately or
severely abnormal (high risk) myocardial perfusion study of
single-photon emission computed tomography (SPECT) and
positron emission tomography (PET). A higher discriminatory
power of PET is demonstrated. Modiﬁed from Shaw et al. (20).
Figure 5. Impact of CFR Measured by Positron Emission
Tomography on the Prognosis in Diabetic Individuals
The graph demonstrates the cardiac mortality rate in 2,423
individuals with and without diabetes, with and without
pre-existing coronary artery disease (CAD), and with normal versus
impaired myocardial ﬂow reserve. It is demonstrated that diabetic
individuals without pre-existing CAD are not a homogeneous
population. Although the subgroup with impaired coronary ﬂow
reserve (CFR) has a cardiac mortality rate similar to that of those
individuals with pre-existing CAD, diabetic patients with normal
CFR have a prognosis similar to that of nondiabetic individuals.
DM ¼ diabetes mellitus; NI. MPI/EF ¼ normal myocardial perfusion
imaging and ejection fraction. Modiﬁed from Murthy et al. (23).
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719Myocardial perfusion imaging with PET and
SPECT has strong prognostic power. PET has
superior spatial resolution compared with SPECT
and in addition permits the quantitative (as opposed
to qualitative) measurement of myocardial perfu-
sion. Coronary ﬂow reserve, which can be obtained
by dividing myocardial perfusion during exercise by
perfusion at rest, has been shown to have strong
prognostic power for cardiac mortality. Normal
coronary ﬂow reserve, even in high-risk patient
groups such as those with diabetes, is associated
with lower mortality.
A speciﬁc and important feature of nuclear car-
diology methods is the fact that they can be used for
molecular imaging. This means that by using spe-
ciﬁc tracers, molecular mechanisms, or structures
such as cell surface receptors can be visualized. As an
example, Bucerius et al. (25) could demonstrate that
vascular nicotinic acetylcholine receptors can be
visualized with speciﬁc antibodies that were marked
by 18F sodium ﬂuoride (18F) and that patients with
Parkinson disease, even in the vascular system, have
a lower concentration of receptors than healthy
controls. Several other papers published in 2012 also
highlighted the fact that cardiac PET provides
insight into physiological and pathophysiological
processes on a molecular level. As an example, it is
assumed that 18F is a marker for bone formation and
active calciﬁcation, and it was demonstrated that
increasing amounts of coronary artery calciﬁcation
are associated with increasing coronary artery uptake
of 18F sodium ﬂuoride (but not 18F-ﬂuorodeox-
yglucose, a marker of metabolic activity in cardiacPET) (26). Similarly, in patients with aortic valve
stenosis, increased 18F activity was observed, with a
closer association between 18F activity (marker of
calciﬁcation) and stenosis severity than between 18F-
ﬂuorodeoxyglucose uptake (marker of inﬂammation)
and stenosis severity (27).
Molecular imaging of the renin-angiotensin sys-
tem could be of particular importance because it
plays an important role in normal and pathological
remodeling of the left ventricular myocardium after
myocardial infarction. Interindividual variations of
the renin-angiotensin system could explain why
some patients display pronounced remodeling of the
left ventricle (with ventricular dilation and reduced
ejection fraction) and some others do not. It might
also explain the variability of response to treatment
with antagonists of the renin-angiotensin system.
Dilsizian et al. (28) used lisinopril-labeled with
technetium-99m to successfully image human
myocardial tissue angiotensin-converting enzyme
overexpression in transgenic rats by external micro
SPECT/CT (28). Fukushima et al. (29) used a
11C-labeled ligand to the AT1 receptor to study
the regional expression of the AT1 receptor in pigs
after myocardial infarction and in human control
subjects by PET/CT. They found a regionally
homogeneous uptake in healthy myocardium. In
infarcted myocardium, the density was reduced.
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infarcted areas, the speciﬁc receptor-associated ac-
tivity was higher in infarcted areas compared with
normal myocardium, indicating upregulation of the
AT1 receptor in infarcted myocardium (Fig. 6).
Similarly, expression of the receptor was increased
in the remote myocardium of infarcted pigs
compared with healthy controls. In healthy human
individuals, olmesartan suppressed ligand uptake.
In the future, imaging of the renin-angiotensin
system could not only provide in vivo scientiﬁc
insight into the mechanisms of post-infarct
remodeling, but, given the presence of interindi-
vidual variations, also help to identify targeted ap-
proaches to heart failure therapy in different
individuals (30).
Because nuclear cardiology methods use radio-
tracers that actively emit signals (as opposed to, for
example, the passive attenuation in CT), very low
tracer concentrations can be detected. Suitable, se-
lective, and speciﬁc tracers provide for visualization
of molecular structures and processes and for the
analysis of their regional distribution by SPECT
and PET. Next to expanding scientiﬁc knowledge,
such imaging approaches may help to select and
guide targeted therapies in the future.Figure 6. Visualization of Myocardial Perfusion and of the Regiona
Anterior Myocardial Infarction
There is reduced activity of the tracer in infarcted myocardium. Howev
(and therefore receptor expression) is higher in infarcted myocardium
CT ¼ computed tomography; HLA ¼ horizontal long axis; SA ¼ short ax
from Fukushima et al. (29).Cardiac Magnetic Resonance
CMR offers several major areas of application: im-
aging of cardiac morphology and function; analysis
of myocardial perfusion during rest and stress;
myocardial tissue characterization including imag-
ing scar, inﬁltration, ﬁbrosis, and iron; and magnetic
resonance coronary angiography, which, however,
remains technically challenging and is infrequently
used in clinical practice.
Morphology and function. CMR is assumed to be
the gold standard for noninvasive evaluation of
cardiac morphology and function. It can be used to
sensitively detect subtle changes in myocardial mass
and global or regional contractile function. Recently,
CMR was applied to analyze changes in global and
regional left ventricular function in 20 patients with
ischemic cardiomyopathy and therapy with cardiac
stem cells harvested from the right atrial appendage
during bypass surgery (31). In treated patients,
there was signiﬁcant improvement of left ven-
tricular ejection fraction (from 27.5% to 35% after
4 months and 41% after 12 months) and especially
pronounced improvement of myocardial segments
with the greatest contractility at baseline. However,
the results of the reported trial are incompletel Expression of the AT1R in a Pig After
er, after correction for myocardial perfusion, tracer activity
compared with remote myocardium. AT1R ¼ AT1 receptor;
is; VLA ¼ vertical long axis. Panel on right reprinted, with permission,
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721because no data on randomized control groups are
available.
Myocardial perfusion. One of the most frequent
clinical applications of CMR is the investigation of
myocardial perfusion after intravenous injection of
gadolinium during adenosine stress in ﬁrst pass. It
has high spatial resolution and can provide quanti-
tative values of myocardial perfusion during rest and
stress, similar to PET (32). In a study involving 41
patients with suspected coronary artery disease,
CMR at 1.5-T was compared with PET to quan-
titatively analyze myocardial perfusion at rest and
during adenosine stress (33). Both methods had
similar discriminatory power to identify patients
with high-grade coronary artery stenosis (PET:
92% sensitivity, 69% speciﬁcity, area under the
curve ¼ 0.81; CMR: 86% sensitivity, 76% speci-
ﬁcity, AUC ¼ 0.81). There was a good correlationFigure 7. Assessment of Myocardial Perfusion at Rest and During A
41 Patients With Suspected Coronary Artery Disease
(Top) Perfusion defect in the posterolateral wall in a patient with high
correlation of absolute perfusion values during stress by cardiac magn
r ¼ 0.37), good correlation of coronary ﬂow reserve (r ¼ 0.75) and simil
of patients with stenoses $70%. MPR2 ¼ myocardial perfusion reserve
descending artery; RCA¼ right coronary artery. Panel on right reprintedof coronary ﬂow reserve (absolute values of myo-
cardial perfusion at stress divided by rest) measured
with the 2 methods (r ¼ 0.75). However, the
absolute perfusion values at rest (r ¼ 0.32) and
during stress (r ¼ 0.37) showed poor correlation,
indicating the presence of unidentiﬁed, systematic
differences between the 2 methods (Fig. 7).
In an investigation of 53 patients, Jogya et al. (34)
validated adenosine stress CMR with a 3-T system
against invasively measured fractional ﬂow reserve
(FFR), the invasive gold standard for identifying
hemodynamically relevant coronary artery stenoses.
CMR demonstrated a sensitivity of 91% and a spec-
iﬁcity of 90% for the identiﬁcation of patients who
had at least 1 stenosis with an invasive FFR #0.75.
For the identiﬁcation of speciﬁc coronary arteries
with a relevant stenosis (FFR #0.75), sensitivity
was 79% and speciﬁcity was 92%. In a similar studydenosine Stress With 13N Ammonia PET and 1.5-T CMR in
-grade stenosis of the left circumﬂex artery (LX). (Bottom) Poor
etic resonance (CMR) and positron emission tomography (PET) (left,
ar discriminatory power of CMR and PET regarding the identiﬁcation
for the lowest 2 segments of each territory; LAD ¼ left anterior
, with permission, from Morton et al. (33).
Table 1. Diagnostic V
Coronary Artery Sten
No. o
Publicat
SPECT 105
CMR 7
PET 11
Reprinted, with permissi
CI ¼ conﬁdence inte
PET ¼ positron emission
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722that included 120 patients studied with a 1.5-T
system, 90% sensitivity and 82% speciﬁcity were
found (35).
The CE-MARC (Clinical Evaluation of Mag-
netic Resonance Imaging in Coronary Heart Dis-
ease) study, performed in Leeds, United Kingdom,
received widespread attention. In 752 patients with
suspected coronary artery disease, a combined CMR
protocol including rest and stress myocardial
perfusion, left ventricular function, late gadolinium
enhancement (LGE) imaging to identify scar, and
magnetic resonance coronary angiography was
compared with rest/stress SPECT myocardial
perfusion imaging regarding the identiﬁcation of
coronary artery stenoses (36). The combined CMR
protocol had 86.5% sensitivity and 83.4% speciﬁcity.
For SPECT, 66.5% sensitivity and 82.6% speciﬁcity
were reported. MR coronary angiography, however,
was assessable in only 55% of patients. If the results
of magnetic resonance coronary angiography were
not taken into account, sensitivity of magnetic
resonance was 81.6% and speciﬁcity was 85.9%
(with, however, wide conﬁdence intervals [CIs] so
that it cannot be concluded that magnetic resonance
coronary angiography signiﬁcantly improved the
results of the combined magnetic resonance proto-
col). The authors concluded that CMR is superior
to SPECT for the identiﬁcation of patients with
signiﬁcant coronary artery disease. The study is not
undisputed, and some concerns have been raised
concerning SPECT technique and interpretation
(37) and the lack of a core laboratory evaluation
despite a single-center design.
Jaarsma et al. (38) performed a systematic meta-
analysis comparing the diagnostic performance of
myocardial perfusion imaging with SPECT, PET,
and CMR to identify patients with relevant coro-
nary artery stenoses based on 166 published articles.
The 3 methods had a similarly high speciﬁcity (84%
to 89%), but speciﬁcity varied (61% for SPECT,
76% for CMR, and 81% for PET) (Table 1, Fig. 8).alue of SPECT, CMR, and PET to Identify Patients With
osis
f
ions
Sensitivity, %
(95% CI)
Speciﬁcity, %
(95% CI) DOR (95% CI)
88 (88–89) 61 (59–62) 15.3 (12.7–18.5)
89 (88–91) 76 (73–78) 26.4 (17.7–39.5)
84 (81–87) 81 (74–875) 36.5 (21.5–61.9)
on, from Jaarsma et al. (38).
rval; CMR ¼ cardiac magnetic resonance; DOR ¼ diagnostic odds ratio;
tomography; SPECT ¼ single-photon emission computed tomography.The authors concluded that SPECT is inferior
regarding speciﬁcity, the diagnostic performance of
CMR and PET are similar, and the criteria for
selecting the appropriate test for a given patient
should include radiation exposure and local expertise.
CMR myocardial perfusion is a valuable method
to identify hemodynamically relevant coronary ar-
tery stenoses. Performed and interpreted with
expertise, it has a diagnostic performance similar to
that of PET and allows accurate quantiﬁcation of
myocardial perfusion reserve (Fig. 8). Compared
with invasive coronary angiography, however, an
excellent agreement cannot be expected for any
myocardial perfusion imaging modality (whether
with SPECT, PET, or CMR) because coronary
angiography is not a functional test and thus cannot
detect or demonstrate ischemia. Not every coronary
artery stenosis associated with a high-grade diam-
eter reduction actually causes myocardial perfusion
deﬁcits or ischemia.
Myocardial tissue characterization. CMR tissue
characterization includes LGE imaging, which
constitutes an integral part of most CMR studies. It
reliably visualizes myocardial scar, ﬁbrosis, inﬁltra-
tion such as in cardiac amyloidosis, and other
chronic myocardial alterations. Importantly, LGE
carries signiﬁcant prognostic relevance. In a popu-
lation cohort from Iceland, 936 elderly inhabitants
(67 to 93 years of age) were subjected to magnetic
resonance LGE imaging (39). In addition to 91
clinically known myocardial infarctions, CMR
identiﬁed scars subsequent to clinically unnoticed
myocardial infarction in a further 157 patients.
During 6 years of follow-up, the mortality rate was
33% in patients with clinically known myocardial
infarction, 28% in patients with previously unrec-
ognized scars as detected by CMR, and 17% in
patients with normal ﬁndings on LGE imaging.
Abnormalities in LGE imaging remained signiﬁ-
cantly associated with mortality after adjustment for
age and risk factors.
An important area of application for LGE im-
aging is the assessment of viability in areas of
myocardial ischemia and infarction, speciﬁcally the
question whether a speciﬁc region will regain or
improve contractile function after revascularization.
The extent of transmurality of late enhancement as
seen in magnetic resonance imaging is related to the
probability of functional recovery after coronary
revascularization (40). However, not only LGE
imaging, but also dobutamine stress CMR can be
used to assess viability, in which return of contractile
function under low-dose dobutamine infusion pre-
dicts improvement after revascularization. In a
A B
C D
Figure 8. Diagnostic Accuracy of Imaging Modalities for Myocardial Perfusion Regarding the Detection of Coronary Artery Disease
The graphs indicate the accuracy for coronary artery disease detection in the form of receiver-operating characteristics curves for SPECT (A),
CMR (B), PET (C), and a comparison of all 3 curves within 1 graph (D). AUC ¼ area under the curve; SROC ¼ symmetric receiver-operating
characteristics curve; other abbreviations as in Figures 4 and 7. Reprinted, with permission, from Jaarsma et al. (38).
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723meta-analysis of 24 studies with 698 patients,
Romero et al. (41) compared LGE and dobutamine
stress CMR to identify viable infarct areas.
Although LGE CMR displayed higher sensitivity
(95% vs. 81%), dobutamine stress CMR had a
higher speciﬁcity (91% vs. 51%).
The prognostic relevance of revascularization of
viable and nonviable myocardium was investigated in
a trial encompassing 144 patients with a left ven-
tricular ejection fraction #35% (42). The authors
demonstrated that purely medical therapy in patients
with viable myocardium was associated with a worse
prognosis than in patients without viable myocar-
dium (3-year survival rate: 48% vs. 77%, p ¼ 0.02).
If revascularization was performed, prognosis was
not inﬂuenced by the absence or presence of viable
myocardium. A subanalysis of 43 matched patient
pairs showed that in the presence of viable myocar-
dium, the 3-year mortality risk was signiﬁcantlyhigher for patients without revascularization com-
pared with patients in whom revascularization was
performed (HR: 2.5, 95% CI: 1.1 to 6.5) (Fig. 9).
The combination of severe systolic dysfunction
and viable myocardium as assessed by CMR seems
to be a risk factor for mortality if patients are not
revascularized.
Abnormal ﬁndings in LGE imaging are not
limited to myocardial infarction. Fibrosis in the
context of other diseases can also cause such ab-
normalities: in combination with other ﬁndings,
including myocardial edema, LGE in CMR is an
important method to identify acute myocarditis
(although less useful for chronic myocarditis [43]).
LGE is also found, for example, in dilated cardio-
myopathy, hypertrophic cardiomyopathies, sarcoid-
osis, and amyloidosis. Conﬁrming several previous
studies, Levya et al. (44) demonstrated prognostic
relevance in nonischemic cardiomyopathies. In 97
AB
Figure 9. Late Enhancement and Prognosis in Patients With Reduced Ejection Fraction
Viability assessed by CMR LGE imaging, revascularization and 3-year mortality in 43
matched patient pairs, all with a left ventricular ejection fraction #35%. In the presence of
viable myocardium (CR V and M/IR V), 3-year survival is signiﬁcantly reduced if no revas-
cularization is performed (M/IR V). Reprinted, with permission, from Gerber et al. (42).
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724patients who underwent resynchronization therapy,
the HR for cardiac mortality was 18.6 (95% CI: 3.5
to 98.5) if ﬁbrosis was detectable by LGE imaging
(44) (Fig. 10).
Observations in a group of 137 patients scheduled
for placement of an automated implantablecardioverter-deﬁbrillator (ICD) point in the same
direction. The presence (and extent) of abnormalities
inCMRLGEimageswas a predictor for the endpoint
death or adequate ICD discharge, both in patients
with ischemic cardiomyopathy and in patients with
nonischemic cardiomyopathy (45) (Fig. 11).
In patients with hypertrophic cardiomyopathy,
high signal intensity areas on LGE images indicate
ﬁbrosis and can be observed frequently. Their extent
is progressive over time (46). Based on a meta-
analysis of 4 previously published trials, Green
et al. (47) report that these areas were present in
60% of 1,063 patients with hypertrophic cardio-
myopathy (the pattern is typically of patchy nature
and more pronounced in areas of myocardial hy-
pertrophy). For several endpoints, including car-
diovascular mortality and total mortality (odds ratio
[OR]: 4.46), the presence of LGE was signiﬁcantly
predictive. For the prediction of the combined
endpoint sudden cardiac death or adequate ICD
discharge, the OR was 2.35 and, with a 95% CI from
0.87 to 6.58, just missed signiﬁcance (p ¼ 0.091).
This is of clinical relevance because the prediction
of sudden death in patients with hypertrophic car-
diomyopathy is difﬁcult and markers of increased
risk that help to identify patients who would beneﬁt
from ICD therapy or in whom it could safely
be avoided would be very useful. Interestingly,
LGE can even be found in genotype-positive, but
phenotype-negative relatives of hypertrophic car-
diomyopathy patients (48). Clinical implications of
this observation are still unclear.
A strong predictive value of LGE imaging was
also shown in patients with myocarditis. In a study
of 222 patients who were followed on average for 4.7
years, Grün et al. (49) demonstrated high all-cause
(19.2%) and cardiac (15%) mortality rates in the
presence of LGE abnormalities. The presence of
LGE had an HR ratio of 8.4 for all-cause mortality
and 12.8 for cardiac mortality, independent of
clinical symptoms. Importantly, this is superior to
left ventricular ejection fraction, end-diastolic vol-
ume, or New York Heart Association functional
class with HRs between 1.0 and 3.2 for all-cause and
between 1.0 and 2.2 for cardiac mortality rates (49).
In patients with nonischemic myocardial disease,
the presence of LGE indicates irreversible injury,
which is clinically important. Numerous studies in
patients with various clinical conditions demonstrate
the prognostic relevance of the presence and extent of
LGE. In the future, LGE could be a key parameter
for determining the need for ICD placement.
Recently, the direct measurement of magnetic
relaxation times has received a lot of attention.
Figure 10. Typical Mid Wall Sign Obtained by Late Gadolinium Enhancement in a Patient With Nonischemic Cardiomyopathy
In 97 patients with nonischemic cardiomyopathy (left, arrows) scheduled for resynchronization therapy, the presence of abnormal hyperenhancement
(DCM þ MWHE) was associated with a signiﬁcantly worse prognosis compared with patients without detectable hyperenhancement (DCM  MWLE). The
cardiovascular survival curve of patients with ischemic cardiomyopathy (ICM) was between the former 2 groups. DCM ¼ dilated cardiomyopathy; MWHE ¼
midwall hyperenhancement. Reprinted, with permission, from Levya et al. (44).
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725Because the relaxation properties of myocardial
tissue is the underlying mechanism for pathology-
speciﬁc signal intensity changes in images, the
mapping of these times (mainly T1,T2, andT2*)may
overcome problems of signal intensity–based imag-
ing and allow absolute normal and cutoff values to
be established for a more accurate detection of tis-
sue abnormalities. Mapping techniques have been
shown to provide accurate information on the extent
of abnormalities in ischemic and nonischemic heart
disease (50–54), but although they have been vali-
dated and have the potential to replace many of the
current signal intensity–based magnetic resonance
imaging approaches (55), the acquisition techniques
and evaluation procedures are not yet standardized.
Magnetic resonance coronary angiography. Because
of its relatively limited spatial and contrast resolution,
imaging of the coronary arteries by magnetic reso-
nance angiography remains challenging and is not
incorporated into clinical routine, except for the
characterization of coronary anomalies or the iden-
tiﬁcation of large coronary aneurysms as a conse-
quence of Kawasaki disease. In the CE-MARC trial
described previously, addition of the results of CMR
coronary angiography to the otherCMRﬁndings had
some effect on sensitivity and speciﬁcity, but did not
signiﬁcantly improve accuracy. Furthermore, it was
assessable in only 55% of patients (36). Image quality
is substantially lower than for CT coronary angiog-
raphy (Fig. 12). However, most coronary artery
events are caused by atherosclerotic lesions in the
proximal segments of the coronary system and, with
adequate hardware and technique, the proximal cor-
onary segments can be visualized relatively reliably byCMR. Correspondingly, Yoon et al (56), who stud-
ied 207 patients by magnetic resonance whole-heart
free-breathing coronary angiography on a 1.5-T
system and followed the cohort for 25 months,
observed 5 severe cardiac events (1 cardiac death and 4
cases of unstable angina) in 84 patients with signiﬁ-
cant stenosis in the proximal coronary artery seg-
ments, whereas of 123 individuals without proximal
stenosis, none had a severe event (56).
Although magnetic resonance coronary angiog-
raphy continues to be a subject of ongoing research,
image quality is often signiﬁcantly impaired in
clinical routine, and the method plays no routine
role for the identiﬁcation of coronary stenoses.
Real-time CMR. With suitable systems, magnetic
resonance imaging can be performed in real time
and can be used for catheter guidance in a manner
similar to ﬂuoroscopy. Ratankaya et al. (57) have
been able to show that right heart catheterization
can be performed under magnetic resonance guid-
ance and that gadolinium-ﬁlled balloons at the
catheter tip provide better imaging than balloons
ﬁlled with air. Similarly, the use of magnetic reso-
nance has been reported for the real-time guidance
of catheter placement (58,59), but the method is not
considered ready for clinical application.
The use of real-time CMR is a potential concept
for radiation-free, 3D catheter guidance to support
cardiac interventions in the future.
Cardiac CT
The minimum prerequisite for cardiac CT is a
CT systemwith at least 64 detector rows, fast rotation,
Figure 11. Patient With Nonischemic Pattern of Late Gadolinium Enhancement on
Magnetic Resonance Imaging
Event rate (death or adequate implantable cardioverter-deﬁbrillator [ICD] discharge)
depending on left ventricular systolic function (A) and extent of late enhancement (B).
Modiﬁed, with permission, from Klem et al. (45).
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726and the ability to perform electrocardiography-
synchronized data acquisition or reconstruction.
Technology is progressing continuously. On the one
hand, systems with asmany as 320 detector rows have
become available, which in many cases permit
coverage of the entire volume of the heart in a single
cardiac cycle. On the other hand, systems that
combine 2 x-ray tubes and detector arrays (dual-
source CT) have been developed and improve tem-
poral resolution by a factor of 2 compared with
systems with a single x-ray tube. The major targets of
cardiac CT imaging are the coronary arteries because
other noninvasive imaging methods do not permit
imaging of the coronary vessels with comparable
image quality.
Coronary calcium. For many years, CT has been
used to detect and quantify coronary artery cal-
cium. Coronary calcium is a marker of coronary
atherosclerotic plaque and is associated with an
increased risk of future cardiovascular events, as
demonstrated by earlier landmark studies (51) and
conﬁrmed, in various subgroups, by recent trials
and analyses (60–63). Yeboah et al. (64) compared
the predictive value of various novel risk markers
in a population-based study with 6,814 partici-
pants. Over a mean follow-up period of 7.6 years,
94 cardiac events occurred (myocardial infarction,angina with revascularization, and coronary
death). In a multivariable analysis, only coronary
calcium detected by CT (HR: 2.60, 95% CI: 1.94
to 3.50, p < 0.001) and a family history of pre-
mature heart disease (HR: 2.18, 95% CI: 1.38 to
3.42, p < 0.001) were associated with future
events, whereas the ankle-brachial index (HR:
0.79), brachial vasoreactivity (HR: 0.93), carotid
intima–media thickness (HR: 1.17), and highly
sensitive C-reactive protein (HR: 1.28) were not
independently predictive.
Coronary CT angiography. In the past decade,
coronary CT angiography has become a much
more prominent application of cardiac CT than
coronary calcium scoring. The main clinical beneﬁt
is derived from the high negative predictive value of
coronary CT angiography. The ability to reliably
rule out stenosis makes CT a useful tool to rule out
signiﬁcant coronary artery disease in symptomatic
patients with a low pre-test likelihood of disease.
This potentially includes many individuals with
acute chest pain who are often at low risk of
actually having an acute coronary syndrome,
whereas, on the other hand, a missed diagnosis may
have severe consequences. In 2012, 2 large trials
investigated the clinical value of coronary CT
angiography in this situation. Litt et al. (65) ran-
domized 908 of 1,370 patients with acute chest
pain to undergo coronary CT angiography. Of
these 908 patients, 640 could be immediately dis-
charged after negative ﬁndings on a CT scan and
within the following 30 days, no deaths or
myocardial infarctions occurred. However, the
overall rate of events was low: only 10 of 908 pa-
tients in the CT group (all with positive ﬁndings
on CT) and 5 of 464 patients in the traditional care
group experienced a myocardial infraction within
the 30-day follow-up period (1% in each group).
Hoffmann et al. (66) randomized 1,000 low-risk
acute chest pain patients in a multicenter trial, so
that 501 patients underwent coronary CT angiog-
raphy as an initial test; 50% of these patients were
discharged from the emergency department within
8.6 h (as opposed to 26.7 h in the traditional care
group). No patient with negative ﬁndings on CT
(no stenosis >50%) experienced acute myocardial
infarction. Similar to the previous study, the pa-
tients mainly had a low risk, and only 23 myocar-
dial infarctions occurred in the entire patient
cohort (plus 52 cases of unstable angina).
In patients with stable chest pain, coronary CT
angiography is also prognostically relevant.
Numerous publications from the CONFIRM reg-
istry, with a total enrolled patient number of more
Figure 12. Magnetic Resonance Coronary Angiography With a 1.5-T System Acquired
Without Intravenous Contrast in Free Breathing
(A) Magnetic resonance. (B) Corresponding invasive coronary angiogram. The arrows
indicate stenosis of left anterior descending coronary artery. Reprinted, with permission,
from Yoon et al. (56).
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727than 32 000, have demonstrated low total mortality
and cardiac event rate if coronary CT angiography
showed no coronary stenosis and no coronary
atherosclerotic plaque (67). The severity of coronary
artery disease as documented by coronary CT
angiography has prognostic implications. It could be
shown that symptomatic patients with “high-risk
anatomy” (left main stenosis, 3-vessel disease or
2-vessel disease with involvement of the proximal
LAD) proﬁt from revascularization, while patients
with lower-risk coronary anatomy do not (68). In a
similar trial including 2,977 patients, Cho et al. (69)
demonstrated that in patients with suspected coro-
nary artery disease, coronary CT angiography
(maximum degree of stenosis) had a higher prog-
nostic value than stress electrocardiography (69).
An important question is whether coronary CT
angiography could (and should) also be used for risk
stratiﬁcation of asymptomatic individuals. Within
the CONFIRM registry, 7,590 patients without
chest pain could be identiﬁed. Coronary CT angi-
ography was prognostically relevant in these in-
dividuals. After adjustment for Framingham risk
score, patients with stenoses >50% in 2 or 3 vessels
(but not patients with a stenosis only in 1 vessel or
lesions that were not considered hemodynamically
relevant) had a worse prognosis (70). However, HRs
were relatively low (2.2 for 2-vessel disease and 2.9
for 3-vessel disease). Of particular interest is the
observation that after adding coronary calcium to
the Framingham risk score, coronary CT angiog-
raphy did not incrementally improve risk stratiﬁca-
tion (70).
Coronary CT angiography has a high accuracy
for detection of coronary artery stenoses. There is a
growing body of evidence concerning prognostic
implications of coronary CT angiography. Uni-
formly, the trials report very good prognosis when
coronary CT angiography ﬁndings are normal.
However, most of the respective studies and ana-
lyses were performed in patient groups with a very
low baseline risk, so that even with abnormal
ﬁndings on CT, the risk is increased, but not
greatly. Studies in patient groups with higher
baseline risk will be necessary to better understand
the overall prognostic potential of coronary CT
angiography.
Late enhancement, CT perfusion, and FFR. In a
fashion similar to CMR, contrast-enhanced CT
permits investigation of myocardial contrast
enhancement. Instead of gadolinium, iodinated
contrast agent is used, which displays kinetics
similar to those of gadolinium. Myocardial perfu-
sion can be analyzed in ﬁrst pass, and areas of scarand ﬁbrosis cause late enhancement. In case of acute
coronary interventions, the contrast injected during
the invasive coronary procedure can be used to assess
late enhancement by CT. Sato et al. (71) demon-
strated in 102 patients with a ﬁrst myocardial
infarction that the extent of late enhancement
quantiﬁed immediately after the acute intervention
correlates with the prognosis during the next
24 months (Fig. 13).
Regarding ﬁrst-pass assessment of myocardial
perfusion, some earlier work in small patient
groups is available from previous years. In 2012,
George et al. (72) investigated 50 patients in a
320-slice system. The authors aimed to clarify
whether adding CT myocardial perfusion to CT
coronary angiography would improve agreement
with SPECT myocardial perfusion imaging. As
expected, the agreement of SPECT and CT
angiography alone was not very good; CT angi-
ography had a sensitivity of 56% and speciﬁcity of
75% for the identiﬁcation of SPECT perfusion
defects. CT perfusion imaging had closer agree-
ment: 72% sensitivity and 91% speciﬁcity. The
most valid comparison standard is invasive coronary
angiography with FFR measurement. Ko et al. (73)
validated coronary CT angiography with and
without additional CT myocardial perfusion during
adenosine stress in 40 patients compared with
invasive coronary angiography and FFR (73). For
the detection of coronary stenosis that was hemo-
dynamically relevant (FFR #0.8), sensitivity of
coronary CT angiography alone was 95% and
speciﬁcity was 78%. By adding CT perfusion,
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Figure 13. Late Enhancement in a Patient After Acute Anterior
Myocardial Infarction, Here Color-Coded in Red
The image was acquired immediately after acute PCI, without
additional contrast injection. Total mass of infarcted area is 63.4 g.
Curves of survival free of further cardiac events (cardiac death and
heart failure) depending on the overall mass of infarcted territory
as quantiﬁed by computed tomography late enhancement. Tertile
1: <11 g; Tertile 2: 11 to #36 g, Tertile 3: $36 g. Reprinted, with
permission, from Sato et al. (71).
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728sensitivity was reduced to 87%, but speciﬁcity
increased to 95% (Fig. 14).
In addition to the analysis of perfusion through
direct visualization of myocardial enhancementFigure 14. Adenosine Stress CT Myocardial Perfusion Imaging
The images demonstrate myocardial hypoperfusion in the left anterior
tomography (CT) perfusion imaging under adenosine stress. Reconstruc
myocardium can clearly be distinguished from normally perfused myoca
from Ko et al. (73).during adenosine stress imaging, computationally
elaborate simulations permit to obtain FFR values
from anatomic coronary CT angiography data ac-
quired at rest (74,75) (Fig. 15). After the initial
results of this method had been presented in the
relatively small DISCOVER-FLOW (Diagnosis of
Ischemia-Causing Stenoses Obtained Via Nonin-
vasive Fractional Flow Reserve) trial in 2011 (76),
the results of a larger follow-up trial (DeFACTO
[Determination of Fractional Flow Reserve by
Anatomic Computed Tomographic Angiography]
trial) were presented in 2012. In 252 patients, CT
angiography with determination of FFRCT was
compared with catheter-based coronary angiography
with invasive measurement of FFR (77).
In this trial, the sensitivity of FFRCT to identify
patients with at least 1 stenosis that had an invasively
measured FFR value <0.8 was 90%, but speciﬁcity
was only 54%. For coronary CT angiography alone,
without consideration of FFRCT, sensitivity was 84%
and speciﬁcity was 42%. Overall, the results of the
DeFACTO trial were a little worse than the results
of the initial, smaller DISCOVER-FLOW study.
More data from various centers, however, will bedescending artery territory (arrow) in contrast-enhanced computed
tions are created in typical orientations, and the hypoenhanced
rdium, which has higher CT attenuation. Reprinted, with permission,
Figure 15. Fractional Flow Reserve Determination by Coronary CT Angiography
CT angiography (A), invasive coronary angiography (B), and CT-derived fractional ﬂow reserve (C) in a patient with a proximal right coronary
artery stenosis (arrows). Both invasive fractional ﬂow reserve (FFR) (0.92) and CT-derived fractional ﬂow reserve (FFRCT) (0.89) indicate that the
stenosis is not hemodynamically relevant. The example is taken from a trial in which invasively measured FFR and FFRCT were compared in
53 patients (74) and good agreement was found (area under the curve ¼ 0.94). In this trial, FFRCT was also compared with the transluminal
attenuation gradient (TAG) (D), a further measure that has been suggested to assess the hemodynamic relevance of coronary artery stenoses
by CT (75), and FFRCT proved superior (area under the curve for TAG: 0.63; p < 0.001), but the advantage of FFRCT was no longer signiﬁcant if
analysis was limited to calciﬁed vessels (area under the curve ¼ 0.92 for FFRCT vs. 0.75 for TAG and 0.80 for stenosis assessment by CT
angiography alone). The Editors thank James Min of Weil-Cornell Medical College, New York, for providing the ﬁgure.
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729required to precisely deﬁne the clinical utility of
CT-based FFR measurements.
Myocardial perfusion during adenosine stress
imaging and FFRCT serve to add functional infor-
mation to the purely anatomic information obtained
by coronary CT angiography. This may serve to
reduce the false-positive rate of coronary CT angi-
ography. This false-positive rate is partly caused by
the limited spatial and temporal resolution of CT,
making some lesions appear anatomically more high
grade than they actually are, and partly caused by the
fact that not all stenoses with a diameter reduction
>50% or even >70% cause ischemia, and, by ne-
cessity, the correlation between anatomic and
functional tests for coronary artery disease can never
be perfect.
Atherosclerotic plaque. By CT, not only the coro-
nary artery lumen but, image quality permitting,coronary atherosclerotic plaque can also be visual-
ized and analyzed. Coronary plaque in CT angi-
ography has been shown to have prognostic relevance
(78–80). In the context of reﬁned risk stratiﬁcation,
not only the presence of plaque, but more speciﬁcally
the identiﬁcation of vulnerable plaquedlesions that
have a high likelihood to rupture or erode and cause
acute coronary syndromes in the futuredis of
particular interest. Previous work has demonstrated
that CT characteristics of such lesions include the
absence of bulky calciﬁcation, the presence of
positive remodeling, and low CT attenuation (<30
Hounsﬁeld units) within the plaque (81). In addition,
spotty calciﬁcation, even though not sharply deﬁned,
has repeatedly been mentioned as a marker of
vulnerable plaque. In an ex vivo investigation of 21
coronary arteries, Maurovich-Horvat et al. (82)
demonstrated that the napkin-ring sign, a ringlike
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730enhancement after contrast injection, was present in
38 of 238 plaques and that this sign had a very high
speciﬁcity (98.9%) for the presence of advanced
plaque in histology. Watabe et al. (83) investigated
107 patients in whom percutaneous coronary inter-
vention was performed because of stable chest pain.
Coronary CT angiography was performed in all
patients before percutaneous coronary intervention.
Although post-procedural troponin increase devel-
oped in 36 patients, it did not develop in 71. In
patients with increased troponin, the target lesion
had a signiﬁcantly larger remodeling index on CT
(1.20 vs. 1.04), it more frequently showed spotty
calciﬁcation (50% vs. 11%), and the lesion had a
signiﬁcantly lower density (43 vs. 94 Hounsﬁeld
units) than in patients without a troponin increase.
On multivariable analysis, spotty calciﬁcation (OR:
4.27) and positive remodeling (OR: 4.54) were
independent predictors of troponin increase
(Fig. 16).
If image quality is sufﬁcient, CT permits
the analysis of coronary atherosclerotic lesions re-
garding properties that are associated with plaque
vulnerability.Whether these characteristic properties
permit clinical risk stratiﬁcation and identiﬁcation of
at-risk individuals requires further evaluation.Figure 16. Invasive Coronary Angiography and Coronary CT Angio
to Post-Procedural Troponin Increase
Invasive coronary angiography (A) and coronary CT angiography (B). In
and E which demonstrate serial cross-sections of the lesion in CT angiog
calciﬁcation,” and low CT attenuation (16 HU). The lesion also demonstra
of investigation in this trial. Reprinted, with permission, from Watabe eCatheter-based aortic valve replacement. Trans-
catheter aortic valve replacement has developed into
a major application for cardiac CT. In this context,
CT is used to obtain information about peripheral
access, to identify obstacles in the aorta, and to
obtain the exact dimensions of the aortic root (84).
Several earlier publications demonstrated that CT
provides different dimensions of the aortic root and
especially of the aortic annulus than does echocar-
diography (85). Based on retrospective analyses,
they suggested that CT-based sizing of the
implanted prosthetic aorta might be superior to
echocardiography-based sizing, with beneﬁcial ef-
fects on the prevalence of post-procedural aortic
regurgitation (which, in turn, is a relevant predictor
of outcome [86]). In 2012, this was also demon-
strated in a prospective trial (87). Jilaihawi et al. (87)
used 2D transesophageal echocardiography (TEE)
to measure the aortic annulus and choose the
prosthesis size in 96 patients; they used CT in 40
different patients in whom prosthesis size was
chosen according to the perimeter of the aortic
annulus measured on CT. Paravalvular aortic
regurgitation of more than a mild degree was pre-
sent in 7.5% of patients with CT-based sizing and
21.9% of patients with TEE-based sizing. Similarly,graphy of a Right Coronary Artery Lesion, the PCI of Which Led
CT, the typical features of “vulnerable plaque” are identiﬁable (C, D,
raphy). There is positive remodeling (remodeling index 1.28), “spotty
tes the “napkin ring sign” (D), even though this was not a speciﬁc area
t al. (83).
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731Hayashida et al. (88) showed that CT-based sizing
resulted in a prosthesis size on average 0.8 mm
larger than TEE-based sizing and that it was
associated with a lower rate of severe paravalvular
regurgitation. A further piece of clinically useful
information that can be obtained from CT is the
prediction of suitable ﬂuoroscopic projection angles
that yield an orthogonal view of the aortic valve
plane (89,90). This is of importance because it may
lower the amount of contrast agent that is necessary
to perform the implantation procedure.CT is an important imaging modality in the
workup of patients scheduled for transcatheter aortic
valve replacement. A consensus document of the
Society of Cardiovascular Computed Tomography
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